183 lines
38 KiB
Markdown
183 lines
38 KiB
Markdown
+---------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------+
|
||
| Physicians’ Perspectives on Patient Adherence to Inhaled Maintenance Therapy: | |
|
||
| | |
|
||
| A Cross-Sectional Comparison of Extended-Dose and Standard Packaging | |
|
||
| | |
|
||
| Study Questionnaire – Draft 03 (24/09/2026) | |
|
||
+=================================================================================+======================================================================================================================================================+
|
||
| Basic Demographics / | Name ____________________________________________________ |
|
||
| | |
|
||
| Doctor details | Qualification: MBBS / MD (Chest) / DM (Pulmo / DNB / D3CH) / MD (Med) / DNB (Med) |
|
||
| | |
|
||
| | Any other, please specify: _________________________________________ |
|
||
| | |
|
||
| | Years of Practice: __________________________ |
|
||
| | |
|
||
| | Practice setting: Private Clinic / Private Hospital / Govt. Hospital |
|
||
| | |
|
||
| | Specialization: Chest Physician / Consulting Physician / General Physician / |
|
||
| | |
|
||
| | Other (please specify) _______________ |
|
||
| | |
|
||
| | City _________________________________ State _____________________ |
|
||
+---------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------+
|
||
| Physician practice profile | - On an average how many patients do you see per month? |
|
||
| | |
|
||
| | _______________ |
|
||
| | |
|
||
| | - Approximately how many asthma patients do you manage per month? |
|
||
| | |
|
||
| | - New patients: ___ |
|
||
| | |
|
||
| | - Follow-up/old patients: ___ |
|
||
| | |
|
||
| | - Approximately how many COPD patients do you manage per month? |
|
||
| | |
|
||
| | - New patients: ___ |
|
||
| | |
|
||
| | - Follow-up/old patients: ___ |
|
||
+---------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------+
|
||
| Foracort prescribing pattern | Approximately what proportion of your asthma patients receive Formoterol/Budesonide |
|
||
| | |
|
||
| | - _____ % |
|
||
| | |
|
||
| | Approximately what proportion of your COPD patients receive Formoterol/Budesonide |
|
||
| | |
|
||
| | - ? _____ % |
|
||
| | |
|
||
| | - Among your patients receiving Foracort, approximately what proportion do you prescribe: |
|
||
| | |
|
||
| | ------------------------------------------------------------------------ |
|
||
| | Pack type Asthma COPD |
|
||
| | ------------------------ --------------- --------------- --------------- |
|
||
| | Regular Pack¹ pMDI ___% ___% |
|
||
| | |
|
||
| | Rotacap ___% ___% |
|
||
| | |
|
||
| | Extended- Dose Pack² pMDI ___% ___% |
|
||
| | |
|
||
| | Rotacap ___% ___% |
|
||
| | |
|
||
| | Total Rotacap 100% 100% |
|
||
| | ------------------------------------------------------------------------ |
|
||
| | |
|
||
| | +--------------------------------------------------------------------------------------------------------+ |
|
||
| | | ^(1:) Regular Pack - Formoterol/Budesonide 200 & 400mcg - Rotacaps (pack of 30) & MDI (120 doses) | |
|
||
| | | | |
|
||
| | | ² : Extended-Dose Pack - Formoterol/Budesonide 200 & 400 mcg - Rotacaps (pack of 60) & MDI (180 doses) | |
|
||
| | | | |
|
||
| | | Ref: 1 : Note: The unit dose cost for DPI & MDI remains same irrespective of the pack size | |
|
||
| | +========================================================================================================+ |
|
||
| | +--------------------------------------------------------------------------------------------------------+ |
|
||
+---------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------+
|
||
| Physician assessment of adherence | - Based on your clinical experience, approximately what proportion of patients are adherent to their prescribed treatment? |
|
||
| | |
|
||
| | (Please provide your estimate out of 100 patients) |
|
||
| | |
|
||
| | ------------------------------------------------------------------------ |
|
||
| | Pack type Asthma COPD |
|
||
| | ------------------------ --------------- --------------- --------------- |
|
||
| | Regular Pack pMDI ___ / 100 ___ / 100 |
|
||
| | |
|
||
| | Rotacap ___ / 100 ___ / 100 |
|
||
| | |
|
||
| | Extended- Dose-Pack pMDI ___ / 100 ___ / 100 |
|
||
| | |
|
||
| | Rotacap ___ / 100 ___ / 100 |
|
||
| | ------------------------------------------------------------------------ |
|
||
+---------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------+
|
||
| Physician assessment of adherence | Compared with patients receiving the regular pack, adherence among patients receiving the extended-dose pack is: |
|
||
| | |
|
||
| | - Much better |
|
||
| | |
|
||
| | - Somewhat better |
|
||
| | |
|
||
| | - No difference |
|
||
| | |
|
||
| | - Somewhat worse |
|
||
| | |
|
||
| | - Much worse |
|
||
| | |
|
||
| | - Unable to assess |
|
||
+---------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------+
|
||
| Reasons for non-adherence | - In your opinion What are the key barriers to adherence to inhaled maintenance therapy of formoterol/budesonide in your asthma and COPD patients? |
|
||
| | |
|
||
| | - Side effects |
|
||
| | |
|
||
| | - Lack of understanding of the need for regular treatment |
|
||
| | |
|
||
| | - Delay in refill due to poor accessibility |
|
||
| | |
|
||
| | - Perception that medication is not required when symptoms improve |
|
||
| | |
|
||
| | - Fear/concerns about long-term medication |
|
||
| | |
|
||
| | - Cost |
|
||
| | |
|
||
| | - Difficulty remembering to take doses |
|
||
| | |
|
||
| | - Inhaler technique difficulties |
|
||
| | |
|
||
| | - Patient lifestyle/work-related factors |
|
||
| | |
|
||
| | - Other (Specify): _____________________________________________ |
|
||
+---------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------+
|
||
| Patient characteristics associated with adherence | - Which patients, in your opinion, are most likely to benefit from an Extended dose Pack? |
|
||
| | |
|
||
| | - Elderly patients |
|
||
| | |
|
||
| | - Difficulty in accessing the pharmacy for a refill (e.g. Remote location) |
|
||
| | |
|
||
| | - Patients with frequent exacerbations |
|
||
| | |
|
||
| | - Patients frequently forgetting doses |
|
||
| | |
|
||
| | - Patients taking multiple medications |
|
||
| | |
|
||
| | - Patients with poor disease awareness |
|
||
| | |
|
||
| | - All patients requiring long-term maintenance therapy |
|
||
| | |
|
||
| | - Busy Lifestyle / working professional |
|
||
| | |
|
||
| | - Frequent travellers |
|
||
| | |
|
||
| | - Caregiver-dependent patients |
|
||
| | |
|
||
| | - Other: ______ |
|
||
+---------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------+
|
||
| Physician perspective on the Extended-Dose Pack | - What do you consider the main advantages / disadvantages of the Extended-Dose Pack compared to Regular Pack |
|
||
| | |
|
||
| | Advantages: ________________________________________________________ |
|
||
| | |
|
||
| | Disadvantages: ____________________________________________________ |
|
||
+---------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------+
|
||
|
||
- Overall, how would you rate the Extended-Dose Pack compared with the Regular Pack with respect to:
|
||
|
||
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|
||
Attribute Strongly disagree Disagree Neither agree nor disagree Agree Strongly Agree
|
||
---------------------------------------------------------------------------------------------------------------- ------------------- ---------- ---------------------------- ------- ----------------
|
||
|
||
|
||
Using an adherence pack is more convenient for patients ○ ○ ○ ○ ○
|
||
|
||
Using an adherence pack reduces the frequency of medication refills ○ ○ ○ ○ ○
|
||
|
||
Using an adherence pack improves medication adherence ○ ○ ○ ○ ○
|
||
|
||
Using an adherence pack helps in maintaining treatment continuity ○ ○ ○ ○ ○
|
||
|
||
Using an adherence pack improves patient satisfaction ○ ○ ○ ○ ○
|
||
|
||
Using an adherence pack helps achieve better disease control ○ ○ ○ ○ ○
|
||
|
||
Using an adherence pack is more cost-beneficial for patients because it reduces the frequency of doctor visits ○ ○ ○ ○ ○
|
||
|
||
Using an adherence pack may be detrimental because it can delay follow-up visits with the doctor ○ ○ ○ ○ ○
|
||
|
||
Patients are reluctant to bear the higher initial purchase amount
|
||
|
||
Higher chance of damage to Rotacaps due to humidity in the extended-dose pack
|
||
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|